
GLOW 70mg
$128.00
GLOW is a proprietary multi-peptide research blend featuring GHK-Cu (50mg), BPC-157 (10mg), and TB-500 (10mg), strategically formulated to support advanced investigations into cellular communication, tissue regeneration, angiogenesis, and extracellular matrix remodeling. By combining three extensively studied bioactive peptides, GLOW provides researchers with a comprehensive platform for exploring the synergistic interactions that influence healing, recovery, and cellular resilience.
At the core of the formulation is GHK-Cu, a naturally occurring copper-binding peptide recognized for its role in cellular signaling, tissue remodeling, collagen synthesis, and regenerative processes. Complementing this activity is BPC-157, a peptide widely investigated for its involvement in angiogenesis, tissue repair pathways, and cellular recovery mechanisms. The blend is further enhanced by TB-500, a synthetic analog of Thymosin Beta-4, which has been studied for its effects on cellular migration, actin regulation, tissue remodeling, and regenerative adaptation.
Together, these peptides create a multifaceted research model for examining the biological processes underlying wound healing, connective tissue maintenance, vascular development, and cellular regeneration. Researchers have utilized similar peptide combinations to investigate how coordinated signaling pathways may influence tissue repair, inflammatory responses, extracellular matrix integrity, and recovery from physiological stress.
Beyond regenerative applications, GLOW offers a unique opportunity to study peptide-receptor interactions, cellular communication networks, and the complex molecular mechanisms that govern tissue homeostasis and adaptation. Its broad biological relevance has generated interest across multiple disciplines, including regenerative medicine, dermatological science, musculoskeletal biology, and healthy aging research.
“GLOW” GHK-Cu | TB-500 | BPC-157
Appearance: Blue Powder
GHK-Cu
CAS NO: 49557-75-7
Molecular Formula: C14H24N6O4
Molecular Weight: 340.39
TB-500 (TB-4) 43 amino acid chain
CAS NO: 77591-33-4
Molecular Formula: C212H350N56O78S
Molecular Weight: 4963 g/mol
BPC-157
CAS NO: 137525-51-0
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.54
Research Use Only
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.
Legal Disclaimer
This product and any associated information have not been evaluated by the U.S. Food and Drug Administration (FDA). No representations or warranties are made regarding its use for the diagnosis, treatment, cure, or prevention of any disease. Use is strictly limited to qualified professionals operating in properly equipped and certified laboratory environments.
Terms of Sale
By purchasing from Cutting Edge Compounds, the buyer certifies that they are a qualified researcher or represent a licensed institution. The buyer assumes full responsibility for ensuring compliance with all applicable laws and regulations governing the purchase, handling, storage, and use of this product. All sales are final.
STRENGHT | BATCH/LOT | RECEIVED | PURITY (%) | COA |
70mg | CEC-GLW-70-01 | April 2026 | 99.4% |
|---|
This product is intended solely for in vitro laboratory research purposes. It is not approved for human or animal use and must not be used in food, dietary supplements, pharmaceuticals, or cosmetic applications. All products arrive in lyophilized (freeze-dried) powder form.
Cutting Edge Compounds
We take pride in delivering high-quality research products you can trust. All of our products are made using premium-grade ingredients and undergo rigorous testing to ensure purity, potency, and consistency.
Contact
Helpful links
support@cuttingedgecompounds.com
MAILING ADDRESS
19510 Van Buren Blvd #F3-292
Riverside, Ca 92508


Please note that all products featured on this website are intended strictly for research and development purposes only. They are not designed for human consumption. The statements made on this website have not been evaluated by the U.S. Food and Drug Administration, and our products are not intended to diagnose, treat, cure, or prevent any disease. Cutting Edge Compounds operates solely as a chemical supplier. We are not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor are we an outsourcing facility as defined under Section 503B of the same act.
©2024 Cutting Edge Compounds · All Rights Reserved
